Article révisé par les pairs
Résumé : Clinical benefits of atezolizumab plus bevacizumab (atezolizumab-bevacizumab) are observed only in a subset of patients with hepatocellular carcinoma and the development of biomarkers is needed to improve therapeutic strategies. The atezolizumab-bevacizumab response signature (ABRS), assessed by molecular biology profiling techniques, has been shown to be associated with progression-free survival after treatment initiation. The primary objective of our study was to develop an artificial intelligence (AI) model able to estimate ABRS expression directly from histological slides, and to evaluate if model predictions were associated with progression-free survival.

Documents en relation

DI-fusion

  • Systemic Treatments with Tyrosine Kinase Inhibitor and Platinum-Based Chemotherapy in Patients with Unresectable or Metastatic Hepatocholangiocarcinoma.
    par Gigante, Elia , Hobeika, Christian , Le Bail, Brigitte , Paradis, Valérie , Tougeron, David , Lequoy, Marie , Bouattour, Mohamed , Blanc, Jean Frédéric , Ganne-Carrié, Nathalie , Tran, Henri , Hollande, Clémence , Allaire, Manon , Amaddeo, Giuliana , Regnault, Hélène , Vigneron, Paul , Ronot, Maxime , Elkrief, Laure , Verset, Gontran , Trepo, Eric , Zaanan, Aziz , Ziol, Marianne , Ningarhari, Massih , Calderaro, Julien , Edeline, Julien , Nault, Jean Charles
    Publication 2022-09
  • Common genetic variation in alcohol-related hepatocellular carcinoma: a case-control genome-wide association study.
    par Trepo, Eric , Caruso, Stefano , Yang, Jie , Imbeaud, Sandrine , Couchy, Gabrielle , Bayard, Quentin , Letouzé, Eric , Ganne-Carrié, Nathalie , Moreno, Christophe , Oussalah, Abderrahim , Féray, Cyrille , Blanc, Jean Frédéric , Clément, Bruno , Hillon, Patrick , Boursier, Jérôme , Paradis, Valérie , Calderaro, Julien , Gnemmi, Viviane , Nault, Jean Charles , Guéant, Jean-Louis , Devière, Jacques , Archambeaud, Isabelle , Vitellius, Carole , Turlin, Bruno , Bronowicki, Jean-Pierre , Gustot, Thierry , Sutton, Angela , GENTHEP Consortium , Ziol, Marianne , Nahon, Pierre , Zucman-Rossi, Jessica
    Publication 2022-01
  • New concepts in the treatment of hepatocellular carcinoma
    par Sidali, Sabrina , Trepo, Eric , Sutter, Olivier , Nault, Jean Charles
    Publication 2022-11-01
  • Nestin as a diagnostic and prognostic marker for combined hepatocellular-cholangiocarcinoma
    par Calderaro, Julien , Di Tommaso, Luca , Maillé, Pascale , Beaufrère, Aurélie , Nguyen, Cong Trung , Heij, Lara , Gnemmi, Viviane , Graham, Rondel P , Charlotte, Frédéric , Chartier, Suzanne , Wendum, Dominique , Vij, Mukul , Allende, Daniela , Diaz, Alba , Fuster, Carla , Rivière, Benjamin , Herrero, Astrid , Augustin, Jeremy , Evert, Katja , Calvisi, Diego Francesco , Leow, Wei Qiang , Ho Wai Leung, Howard , Bednarsch, Jan , Boleslawski, Emmanuel , Rela, Mohamed , Wing-Hung Chan, Anthony , Forner, Alejandro , Reig, Maria , Pujals, Anaïs , Favre, Loetitia , Allaire, Manon , Scatton, Olivier , Uguen, Arnaud , Trepo, Eric , Otero Sanchez, Lukas , Chatelain, Denis , Remmelink, Myriam , Boulagnon-Rombi, Camille , Bazille, Celine , Sturm, Nathalie , Menahem, Benjamin , Frouin, Eric , Tougeron, David , Tournigand, Christophe , Kempf, Emmanuelle , Kim, Haeryoung , Ningarhari, Massih , Michalak-Provost, Sophie , Kather, Jakob Nikolas , Gouw, Annette S.H. , Gopal, Purva , Brustia, Raffaele , Vibert, Eric , Schulze, Kornelius , Rüther, Darius F. , Weidemann, Sören A , Rhaiem, Rami , Nault, Jean Charles , Laurent, Alexis , Amaddeo, Giuliana , Regnault, Hélène , De Martin, Eleonora , Sempoux, Christine , Navale, Pooja , Shinde, Jayendra , Bacchuwar, Ketan , Westerhoff, Maria , Cheuk-Lam Lo, Regina , Mylène, Sebbagh , Guettier, Catherine , Lequoy, Marie , Komuta, Mina , Ziol, Marianne , Paradis, Valérie , Shen, Jeanne , Caruso, Stefano
    Publication 2022-08-17
  • Clinical profile of patients with primary Sjögren's syndrome with non-identified antinuclear autoantibodies
    par Parisis, Dorian , Sarrand, Julie , Cabrol, Xavier , Delporte, Christine , Soyfoo, Muhammad Shahnawaz
    Publication 2024-04-30